oxid
phospholipid
found
vasculatur
anim
model
atherosclerosi
human
atherosclerot
lesion
inflammatori
diseas
oxid
phospholipid
caus
vascular
nonvascular
cell
initi
inflammatori
reaction
metabolit
arachidon
acid
acid
mimic
inflammatori
properti
oxid
phospholipid
vitro
vivo
normal
highdens
lipoprotein
hdl
normal
apolipoprotein
ai
apolipoprotein
ai
mimet
peptid
like
act
differ
manner
prevent
inflammatori
reaction
characterist
atherosclerosi
associ
decreas
level
oxid
lipid
tissu
cell
hdl
anim
model
atherosclerosi
human
atherosclerosi
human
anim
chronic
inflammatori
diseas
prevent
inflammatori
reaction
characterist
atherosclerosi
may
even
enhanc
inflammatori
reaction
mice
perhap
human
steadyst
plasma
hdlcholesterol
pool
deriv
small
intestin
metabol
phospholipid
gut
bacteria
recent
implic
atherosclerosi
mice
human
studi
apolipoprotein
ai
mimet
peptid
suggest
small
intestin
major
tissu
regul
system
inflamm
mous
model
atherosclerosi
may
import
determin
function
hdl
keyword
apolipoprotein
ai
apolipoprotein
ai
mimet
peptid
highdens
lipoprotein
hydroxyeicosatetraeno
acid
hydroxyoctadecadieno
acid
lipoprotein
oxid
lipid
small
intestin
much
work
field
suggest
oxid
lowdens
lipoprotein
ldl
key
event
atherogenesi
led
enhanc
uptak
foam
cell
format
howev
seen
almost
time
mani
oxid
lipid
oxidizedldl
could
respons
proinflammatori
effect
oxidizedldl
studi
defin
oxid
lipid
led
discoveri
oxid
phospholipid
oxpl
major
class
proinflammatori
lipid
period
studi
explain
highdens
lipoprotein
hdl
influenc
atherogenesi
led
realiz
major
role
provid
antioxid
properti
dampen
proinflammatori
properti
oxidizedldl
turn
led
develop
apolipoprotein
apo
ai
mimet
peptid
other
subsequ
studi
show
peptid
abl
inhibit
atherosclerosi
potent
inhibit
inflamm
surprisingli
wide
varieti
anim
model
diseas
preliminari
studi
human
peptid
administ
oral
dose
mgkg
plasma
level
achiev
low
cmax
ngml
howev
peptid
administr
dose
mg
kg
significantli
improv
hdl
inflammatori
index
wherea
dose
mgkg
second
clinic
trial
decid
achiev
high
plasma
level
peptid
use
low
dose
mgkg
peptid
administ
intraven
subcutan
despit
achiev
high
plasma
level
peptid
cmax
ng
ml
improv
hdl
inflammatori
index
led
reapprais
peptid
effect
mice
led
surpris
discoveri
major
site
action
peptid
may
intestin
even
administ
subcutan
pathway
discoveri
led
us
follow
hypothes
depict
figur
hypothesi
oxid
normal
lipid
metabol
pathway
nonenzymat
mean
produc
oxid
lipid
trigger
inflammatori
respons
mani
tissu
includ
small
intestin
vasculatur
hypothesi
metabolit
arachidon
acid
acid
hete
act
similar
oxpl
induc
inflamm
hypothesi
hdl
contain
protein
enzym
inactiv
remov
proinflammatori
lipid
circumst
system
acut
phase
respons
protein
enzym
associ
hdl
alter
inflammatori
respons
either
inhibit
enhanc
hypothesi
apoai
mimet
peptid
reduc
inflamm
bind
remov
oxid
lipid
tissu
hypothesi
oxid
lipid
small
intestin
import
modul
system
inflamm
intestin
major
site
action
apoai
mimet
peptid
bind
oxid
lipid
articl
review
mani
line
evid
garner
mani
laboratori
led
us
construct
novel
hypothes
hdl
apoai
mimet
peptid
may
influenc
oxid
lipid
metabol
intestin
thu
provid
system
antiinflammatori
antiatherosclerot
properti
phospholipid
integr
compon
mammalian
membran
sourc
substrat
multipl
enzymat
pathway
role
phospholipid
oxid
product
atherosclerosi
recent
review
watson
et
al
subbanagound
et
al
demonstr
liquid
chromatographyelectrospray
ionizationmultistag
mass
spectrometri
oxpl
present
fatti
streak
cholesterolf
rabbit
lesion
apolipoprotein
enul
mice
subbanagound
et
al
also
demonstr
group
posit
oxpl
determin
specif
bioactiv
substitut
stearoyl
palmitoyl
posit
ethanolamin
cholin
posit
phospholipid
alter
bioactiv
subbanagound
et
al
show
part
phospholipid
molecul
requir
bioactiv
bind
oxidizedldl
scaveng
receptor
mice
demonstr
attribut
oxpl
associ
lipid
protein
moieti
lipoprotein
podrez
et
al
demonstr
varieti
oxpl
beyond
describ
watson
et
al
subbagound
et
al
present
lesion
interact
mous
first
suggest
boullier
et
al
simpl
phospholipid
air
oxid
produc
hundr
compound
henc
surpris
myriad
oxpl
found
natur
oxid
lipid
initi
inflammatori
respons
also
form
inflammatori
reaction
understand
sequenc
event
napoli
et
al
follow
time
cours
appear
oxpl
monocyt
aorta
human
fetus
found
presenc
oxpl
preced
appear
monocyt
find
nishi
et
al
highlight
import
oxpl
human
diseas
found
vulner
plaqu
relat
amount
ldl
contain
oxid
phosphatidylcholin
lesion
tsimika
et
al
report
percutan
angioplasti
dramat
increas
plasma
level
oxpl
confirm
presenc
oxpl
clinic
import
lesion
human
cardiolipin
found
bacteria
inner
membran
mitochondria
ldl
tuominen
et
al
report
natur
antibodi
oxid
cardiolipin
bound
oxidizedldl
apoptot
cell
atherosclerot
lesion
antibodi
recogn
nativ
cardiolipin
nativ
ldl
confirm
oxid
phospholipid
occur
inflammatori
condit
vivo
rabbit
human
monkey
rabbit
model
atherosclerosi
tsimika
et
al
demonstr
regress
lesion
oxpl
increas
plasma
decreas
lesion
consist
find
group
human
interestingli
tsimika
et
al
found
oxpl
human
plasma
larg
associ
lp
lipoprotein
strongli
associ
angiograph
document
coronari
arteri
diseas
cad
particularli
patient
year
age
younger
leibundgut
et
al
found
oxpl
also
present
plasminogen
homolog
lp
affect
fibrinolysi
although
known
precis
dietinduc
inflamm
produc
oxpl
process
seem
widespread
natur
fang
et
al
demonstr
oxpl
accumul
lesion
induc
cholesterol
feed
zebra
fish
larva
presenc
oxpl
site
inflamm
restrict
atherosclerosi
exampl
imai
et
al
found
oxpl
lung
human
anim
infect
sever
acut
respiratori
syndrom
saar
anthrax
pulmonari
challeng
inactiv
avian
influenza
viru
rapidli
induc
acut
lung
injuri
oxpl
format
mice
consist
find
crow
et
al
found
mice
markedli
better
surviv
less
oxpl
format
lung
influenza
infect
oxpl
also
found
mucosa
small
intestin
mice
genet
prone
polyp
format
colon
cancer
human
oxpl
found
brain
lesion
patient
multipl
sclerosi
skin
lesion
patient
leprosi
oxpl
also
found
nonalcohol
fatti
liver
diseas
oxpl
level
correl
diseas
sever
human
mous
model
diseas
administr
apoai
mimet
peptid
known
bind
oxpl
extraordinari
high
affin
peptid
significantli
reduc
hepat
fibrosi
howev
author
measur
oxpl
level
studi
presenc
oxpl
human
eye
seen
increas
age
increas
eye
patient
agerel
macular
degener
mous
model
scleroderma
heart
contain
higher
level
antibodi
oxpl
control
tissu
level
antibodi
decreas
administr
peptid
presenc
oxpl
wide
rang
inflammatori
condit
speci
rang
zebra
fish
human
consist
hypothesi
propos
review
studi
cite
section
also
consist
hypothesi
propos
review
vitro
mixtur
oxpl
made
air
oxid
caus
human
aortic
endotheli
cell
ec
bind
monocyt
neutrophil
caus
cell
secret
cytokin
includ
potent
monocyt
chemoattract
factor
monocyt
chemotact
protein
individu
compon
air
oxid
differ
effect
vitro
exampl
stimul
ec
bind
neutrophil
monocyt
wherea
stimul
monocyt
bind
strongli
inhibit
lipopolysaccharidemedi
induct
neutrophil
bind
express
eselectin
protein
mrna
rabbit
vascular
inflamm
seen
tightli
track
content
oxpl
oxid
fatti
acid
malondialdehyd
lesion
interestingli
rel
level
oxid
fatti
acid
deriv
arachidon
acid
linol
acid
oleic
acid
plasma
also
track
well
level
lesion
furnkranz
et
al
directli
appli
oxpl
carotid
arteri
mice
found
arteri
respond
induc
set
atherosclerosisrel
gene
includ
monocyt
chemotact
protein
keratinocytederiv
chemokin
tissu
factor
interleukin
heme
oxygenas
earli
growth
respons
isol
perfus
carotid
arteri
oxpl
trigger
roll
firm
adhes
monocyt
pselectin
keratinocytederiv
chemokinedepend
manner
monocyt
adhes
ec
induc
oxpl
seem
involv
activ
cytosol
phospholipas
inde
mimick
effect
oxpl
honda
et
al
found
pathway
critic
mildli
oxidizedldl
contain
oxpl
induc
monocyt
bind
human
aortic
ec
similar
oxpl
induc
monocyt
neutrophil
bind
human
aortic
ec
number
compound
gener
enzymat
pathway
lipoxygenas
pathway
dramat
increas
crossov
multipl
pathway
abil
lipid
form
undergo
nonenzymat
rearrang
complex
increas
abil
enzym
system
oxid
fatti
acid
biolog
activ
molecul
still
esterifi
cholesterol
phospholipid
thu
biolog
activ
use
exampl
mention
earlier
exampl
number
biolog
activ
oxid
lipid
present
natur
larg
mechan
oxpl
induc
cell
initi
inflammatori
respons
complex
oxpl
seem
oxidationspecif
epitop
recogn
dangerassoci
molecular
pattern
pattern
recognit
receptor
involv
innat
immun
antioxid
enzym
modul
stress
respons
induc
oxpl
oxpl
also
shown
significantli
alter
phenotyp
macrophag
account
characterist
macrophag
note
atherosclerot
lesion
inflammatori
respons
vascular
cell
vitro
vivo
varieti
oxid
lipid
strike
similar
respons
oxpl
metabolit
arachidon
acid
consist
hypothesi
hypothesi
review
role
normal
hdl
mimet
hdl
prevent
inflammatori
reaction
initi
oxid
lipid
involv
multipl
compon
hdl
vitro
studi
demonstr
apoai
mimet
peptid
prevent
format
secret
oxpl
respons
influenza
infect
vivo
peptid
prevent
traffick
macrophag
aorta
respons
influenza
infect
mice
vitro
studi
normal
human
hdl
modul
proinflammatori
respons
human
aortic
ec
oxpl
signal
cascad
antiinflammatori
hdlassoci
enzym
paraoxonas
inhibit
respons
ec
oxpl
vitro
deliv
arteri
vivo
inhibit
respons
balloon
injuri
anoth
compon
normal
hdl
apom
report
bind
oxpl
increas
antioxid
effect
hdl
feed
ldl
receptornul
mice
ldlr
western
diet
wd
induc
format
oxpl
kidney
accompani
inflammatori
chang
similar
arteri
mice
treat
mice
peptid
significantli
reduc
tissu
level
oxpl
significantli
reduc
inflamm
tissu
without
chang
plasma
lipid
level
note
earlier
plasma
lesion
content
oxid
fatti
acid
seem
parallel
one
anoth
administr
peptid
mous
model
atherosclerosi
reduc
plasma
level
oxid
fatti
acid
result
antiinflammatori
hdl
anoth
line
evid
suggest
mechan
apoai
mimet
peptid
work
involv
bind
remov
oxpl
come
find
use
induc
natur
antibodi
recogn
oxpl
would
consist
plasma
increas
oxpl
seen
anim
model
regress
studi
section
consist
hypothesi
hypothesi
propos
review
van
lenten
et
al
first
report
acut
phase
respons
antiinflammatori
hdl
becom
proinflammatori
rabbit
human
subsequ
navab
et
al
report
inject
oxpl
mice
genet
suscept
dietinduc
atherosclerosi
mice
mice
resist
dietinduc
atherosclerosi
hej
mice
induc
acut
phase
respons
elev
apoj
decreas
activ
hedrick
et
al
report
feed
atherogen
diet
ldlr
mice
day
decreas
hepat
mrna
caus
dramat
decreas
plasma
activ
mass
decreas
activ
mass
tempor
relat
increas
lipid
hydroperoxid
content
hdl
decreas
hdlcholesterol
nativ
apoai
apoaii
level
nativ
apoai
disappear
circul
higher
molecular
weight
form
apoai
appear
contain
epitop
recogn
antibodi
recogn
oxpl
present
studi
present
specif
evid
level
variou
compon
oxpl
vessel
wall
function
hdl
mass
function
abil
hdl
prevent
format
oxpl
found
reduc
mice
exposur
mice
secondhand
cigarett
smoke
role
oxpl
modul
hdl
function
previous
review
genet
control
antiinflammatori
properti
hdl
mice
invers
relationship
antiinflammatori
properti
human
abil
hdl
promot
cholesterol
efflux
cholesterol
load
macrophag
report
navab
et
al
vaisar
et
al
report
hdl
patient
coronari
heart
diseas
cad
associ
mani
acut
phase
protein
support
propos
hdl
chang
presenc
chronic
inflamm
effect
chronic
inflamm
hdl
favor
modifi
human
regimen
combin
statin
niacin
treatment
abnorm
hdl
identifi
varieti
inflammatori
state
includ
patient
system
lupu
erythematousu
rheumatoid
arthriti
diabet
mellitu
kontush
chapman
emphas
import
hdl
subpopul
bhattacharyya
et
al
report
human
strong
relationship
activ
hdlassoci
enzym
system
oxid
stress
cardiovascular
risk
moreov
level
metabolit
arachidon
acid
patient
strongli
track
activ
risk
cardiovascular
event
work
undurti
et
al
show
modif
hdl
enzym
releas
macrophag
neutrophil
inflamm
myeloperoxidas
gener
proinflammatori
hdl
particl
level
hemoglobin
potent
oxid
freed
red
blood
cell
haptoglobin
acut
phase
reactant
associ
hdl
cad
patient
significantli
predict
inflammatori
properti
function
hdl
hdl
patient
anoth
chronic
inflammatori
condit
rheumatoid
arthriti
associ
acut
phase
protein
complement
factor
similar
report
patient
cad
modifi
apoai
malondialdehyd
reactiv
carbonyl
block
cholesterol
efflux
atp
bind
cassett
pathway
hdl
atherosclerot
lesion
contain
malondialdehyd
normal
hdl
besler
et
al
report
hdl
patient
stabl
cad
acut
coronari
syndrom
antiinflammatori
properti
present
ec
vitro
stimul
ec
repair
fail
induc
ec
product
found
hdl
subject
activ
endotheli
lectinlik
oxidizedldl
receptor
trigger
endotheli
protein
kinas
c
activ
inhibit
ec
noactiv
pathway
product
identifi
reduc
activ
molecular
mechan
lead
gener
hdl
protein
kinas
c
properti
part
attribut
increas
format
malondialdehyd
hdl
import
hdl
promot
cholesterol
efflux
independ
hdlcholesterol
level
demonstr
studi
khera
et
al
suggest
heineck
possibl
therapeut
target
cavigiolio
et
al
report
oxid
damag
apoai
inhibit
disassoci
apoai
hdl
lipid
poor
form
apoai
critic
promot
cholesterol
efflux
via
atp
bind
cassett
thu
hdl
associ
protein
highli
suscept
modif
lipid
oxid
product
enzym
produc
releas
site
inflamm
protein
enzym
associ
hdl
significantli
chang
proinflammatori
phenotyp
acut
phase
respons
abil
hdl
promot
cholesterol
efflux
antiinflammatori
dramat
reduc
chronic
acut
phase
reaction
seen
cad
patient
studi
section
consist
hypothesi
propos
review
mice
steadyst
plasma
hdlcholesterol
pool
deriv
small
intestin
studi
chylur
human
suggest
similar
fraction
hdl
human
come
small
intestin
metabol
phospholipid
gut
bacteria
recent
implic
atherosclerosi
mice
human
level
oxid
lipid
phospholipid
fatti
acid
germfre
anim
anim
treat
broad
spectrum
antibiot
current
unknown
studi
peptid
suggest
small
intestin
major
tissueregul
system
inflamm
mous
model
atherosclerosi
may
import
site
determin
function
hdl
test
hypothesi
navab
et
al
administ
peptid
equal
dose
oral
subcutan
inject
subcutan
ldlr
mice
wd
plasma
liver
peptid
level
higher
respect
subcutan
administr
wherea
peptid
level
intestin
vari
level
metabolit
arachidon
linol
acid
known
bind
high
affin
peptid
significantli
reduc
intestin
liver
hepat
bile
similar
degre
whether
peptid
administ
subcutan
oral
howev
level
known
bind
peptid
low
affin
unchang
peptid
treatment
reduc
serum
amyloid
triglycerid
level
increas
hdlcholesterol
level
similarli
subcutan
oral
administr
plasma
level
metabolit
arachidon
linol
acid
significantli
correl
serum
amyloid
level
feed
metabolit
arachidon
acid
eg
mous
chow
without
wd
significantli
increas
plasma
serum
amyloid
triglycerid
level
decreas
hdlcholesterol
activ
significantli
amelior
subcutan
administr
peptid
studi
note
feed
ldlr
mice
wd
result
increas
level
free
arachidon
acid
suggest
wd
increas
phospholipas
activ
treatment
peptid
reduc
enterocyt
hepat
level
free
arachidon
acid
consist
reduct
phospholipas
activ
interestingli
level
free
arachidon
acid
similar
enterocyt
small
intestin
liver
mice
howev
level
free
metabolit
arachidon
linol
acid
except
mani
fold
greater
enterocyt
small
intestin
compar
liver
import
phospholipas
activ
intestin
regul
metabol
arachidon
acid
shown
studi
patient
inherit
cytosol
phospholipas
defici
found
impair
eicosanoid
biosynthesi
small
intestin
ulcer
montros
et
al
report
cytosol
phospholipas
protect
cyclooxygenas
inhibitorinduc
intestin
damag
huber
et
al
report
cytosol
phospholipas
mediat
monocyt
adhes
ec
respons
oxpl
watanab
et
al
report
endotheli
specif
delet
mice
result
intestin
inflamm
similar
crohn
diseas
van
leuven
et
al
report
patient
crohn
diseas
evid
system
inflamm
increas
risk
cardiovascular
event
alter
abil
hdl
act
oxpl
oxpl
implic
regul
biofilm
format
bacteria
moreov
oxpl
found
increas
earli
stage
intestin
polyp
format
mous
model
famili
adenomat
polyposi
treatment
mice
peptid
result
decreas
polyp
format
reduc
colon
cancer
treatment
mice
peptid
also
significantli
decreas
plasma
level
lyosphosphatid
acid
shown
lysophosphatid
acid
bind
peptid
affin
nmoll
higher
affin
bind
lysophosphatid
acid
human
apoai
studi
suggest
bind
remov
proinflammatori
lipid
potenti
mechan
inhibit
tumor
develop
mous
model
studi
also
suggest
therapi
target
reduc
inflamm
small
intestin
may
benefit
number
import
human
ill
includ
atherosclerosi
studi
cite
section
consist
hypothesi
hypothesi
propos
review
studi
cite
review
consist
hypothesi
oxid
normal
lipid
metabol
pathway
nonenzymat
mean
produc
oxid
lipid
trigger
inflammatori
respons
mani
tissu
includ
vasculatur
cite
studi
also
consist
hypothesi
metabolit
arachidon
acid
like
mani
oxid
fatti
acid
includ
esterifi
cholesterol
phospholipid
act
similar
oxpl
induc
inflamm
although
biolog
activ
metabolit
arachidon
acid
oxpl
similar
eg
induc
bind
monocyt
neutrophil
ec
pathway
exert
biolog
activ
may
similar
remain
defin
futur
research
studi
describ
review
consist
hypothesi
hdl
contain
protein
enzym
inactiv
remov
proinflammatori
lipid
circumst
system
acut
phase
respons
protein
enzym
associ
hdl
alter
inflammatori
respons
either
inhibit
enhanc
studi
review
also
consist
hypothesi
apoai
mimet
peptid
reduc
inflamm
bind
remov
oxid
lipid
tissu
final
studi
cite
review
consist
hypothesi
oxid
lipid
small
intestin
import
modul
system
inflamm
intestin
major
site
action
apoai
mimet
peptid
bind
oxid
lipid
although
studi
consist
hypothes
definit
proof
hypothes
lack
requir
extens
futur
research
mani
laboratori
free
arachidon
acid
aa
metabol
oxid
fatti
acid
oxaa
acid
phospholipid
pl
also
oxid
oxpl
oxid
lipid
act
endotheli
cell
enterocyt
small
intestin
cell
respond
produc
cytokin
act
liver
cell
macrophag
lead
product
acut
phase
protein
normal
highdens
lipoprotein
nhdl
apolipoprotein
ai
apoai
mimet
peptid
apoai
mimet
block
sequenc
event
howev
acut
phase
reaction
establish
normal
hdl
convert
acut
phase
hdl
aphdl
lose
abil
inhibit
process
may
even
interact
cell
amplifi
acut
phase
reaction
number
shown
figur
relat
hypothes
discuss
text
review
